
CTSH · Nasdaq
The supplied evidence does not establish a consensus rating or how many analysts support each rating. One ChartMill page reports that 37 analysts have analyzed CTSH and gives an average target of $84.31, while a Zacks snippet cites a target range of $80 to $104; those figures imply a high-value cluster but do not constitute a verified consensus. The low end of the cited target evidence is Morgan Stanley’s $44, with Mizuho previously at $64. Wedbush is the most constructive named view after Steven Wahrhaftig upgraded the stock to Outperform and raised the objective by $14; Morgan Stanley is least bullish among the named actions. Weekly revision direction cannot be determined from the supplied dates.